BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1704 related articles for article (PubMed ID: 16112043)

  • 1. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
    Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
    Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
    Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
    Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis.
    Tang Z; Zhou H; Zhang S; Yao X; Hu W; Liu Z; Li L
    Chin Med J (Engl); 1999 Dec; 112(12):1143-6. PubMed ID: 11721457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapidly progressing glomerulonephritis. Microangiitis associated with antibodies against the glomerula membrane].
    Randløv A; Ingemanssen JL; Thomsen BS
    Ugeskr Laeger; 1995 Oct; 157(41):5730-1. PubMed ID: 7571113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
    Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of crescentic glomerulonephritis associated with anti-myeloperoxidase antibody presenting as alveolar hemorrhage].
    Umino T; Ohdama S; Sawada M; Takano S; Miyake S; Tachibana S; Yoshizawa Y; Aoki N; Matsubara O; Tanaka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):277-82. PubMed ID: 8189651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases.
    Bonsib SM; Goeken JA; Kemp JD; Chandran P; Shadur C; Wilson L
    Mod Pathol; 1993 Sep; 6(5):526-30. PubMed ID: 8248108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ANCA-associated vasculitis].
    Sinico RA; Sabadini E; Boeri R; Radice A
    G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.